Infiniplex

Infiniplex is an Israeli startup focused on revolutionizing cancer treatment monitoring using advanced technologies. The company aims to make preemptive, preventive, and follow-up cancer screenings affordable and accessible to everyone by utilizing routine blood testing to screen for genetic tumor biomarkers. This approach addresses the financial and logistical barriers that often limit access to biomarker testing, which can lead to disparities in cancer care. Current methods for monitoring cancer treatment are often complex, time-consuming, invasive, expensive, or ineffective, resulting in late diagnoses and poor patient outcomes. Infiniplex serves healthcare providers and patients in the oncology market, offering a more efficient and less invasive alternative to traditional cancer monitoring methods. The business model is based on providing these innovative blood tests to healthcare facilities and directly to patients, generating revenue through test sales and potentially subscription-based services for ongoing monitoring.

Keywords: cancer, treatment, monitoring, biomarkers, blood testing, affordable, accessible, oncology, innovation, Israeli startup